ECFS 2020 - Optimizing pharmaceutical care in cystic fibrosis

European Cystic Fibrosis Society   311  OPTIMIZING PHARMACEUTICAL CARE IN CYSTIC FIBROSIS MEDICINES OPTIMIZATION IN PATIENTS ON NTM THERAPY CHAPTER 19 References [1] Floto RA, Olivier KN, Saiman L, Daley CL, Herrmann J-L, Nick JA, et al. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of nontuberculous mycobacteria in individuals with cystic fibrosis. Thorax. 2016;71 Suppl 1(Suppl 1):i1-i22. [2] Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases. Am J Respir Crit Care Med. 2007;175(4):367-416. [3] Haworth CS, Banks J, Capstick T, Fisher AJ, Gorsuch T, Laurenson IF, et al. British Thoracic Society Guideline for the management of nontuberculous mycobacterial pulmonary disease (NTM-PD). BMJ open respiratory research. 2017;4(1):e000242. [4] Limited P. Tygacil 50mg powder for solution for infusion. Summary of Product characteristics. Date of first authorisation 24th April 2006, Date of last renewal 22nd February 2016 [Available from: https://www.medi- cines.org.uk/emc/product/200/smpc . [5] Limited MSD. Primaxin IV 500mg/500mg powder for solution for infusion. Summary of Product of characteristics. Date of first authori- sation 30th June 1988, Date of last renewal 8th March 2012. [Available from: https://www.medicines.org.uk/ emc/product/1515 . [6] Limited HU. Amikacin 250mg/ml solu- tion for injection. Summary of product characteristics. Date of first authori- sation 24th January 1996, date of last renewal 23rd May 2001 [Available from: https://www.medicines.org.uk/ emc/product/3784 . [7] NICE. Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes. 2015 [Available from: www.nice.org. uk/guidance/ng5 . [8] Society RP. Medicines Optimisation: Helping patients to make the most of medicines. Good practice guidance for healthcare professionals in England 2013 [Available from: https://www. rpharms.com/Portals/0/RPS%20 document%20library/Open%20 access/Policy/helping-patients-make- the-most-of-their-medicines.pdf .